Logo
  Wednesday, November 20, 2019
Sign-In  |  Sign-Up  |  Contact Us  |  Bookmark 

CEL-SCI receives approval to initiate head and neck cancer trial in Russia - TradingMarkets.com
CEL-SCI Corporation, a biotechnology company, has received governmental approval from the Ministry of Health Care and Social Development of the Russian Federation to begin enrollment of subjects for a Phase III clinical trial of Multikine in Russia. Russia ...more
Print CEL-SCI receives approval to initiate head and neck cancer trial in Russia - TradingMarkets.com Bookmark CEL-SCI receives approval to initiate head and neck cancer trial in Russia - TradingMarkets.com

Related News   
DecJanuary 2011Feb
MoTuWeThFrSaSu
272829303112
3456789
10111213141516
17181920212223
24252627282930
31123456